Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03004326 · ClinicalTrials.gov registry record
Clinical Transcriptomics in Systemic Vasculitis (CUTIS)
A clinical trial of Vasculitis and IgA Vasculitis, sponsored by Peter Merkel.
- Recruiting
- Registry status
- 50
- Enrollment target
- 10
- Study locations
NCT03004326 is a study of Vasculitis and IgA Vasculitis that is actively recruiting participants, run by Peter Merkel. The registered enrollment target is 50 participants, below the 27,314-participant average among 11 other Vasculitis trials with a reported enrollment target (100% lower). The trial reports 10 study locations across 9 states.
The verdict
NCT03004326, a study of Vasculitis and IgA Vasculitis, is actively recruiting participants, sponsored by Peter Merkel.
- RECRUITING
- Registry status
- 50 participants
- Enrollment target
- 10
- Study locations
Study Summary
Multi-center observational study to evaluate the histopathology and transcriptome of cutaneous lesions in patients with several different types of vasculitis.
Conditions Studied
Study Locations (10)
Ontario
- St. Joseph's Healthcare - Hamilton
- University of Toronto Mount Sinai Hospital - Toronto
California
- University of California, Los Angeles - Los Angeles
Massachusetts
- Boston University School of Medicine - Boston
Minnesota
- Mayo Clinic - Rochester
Ohio
- Cleveland Clinic - Cleveland
Oregon
- Oregon Health & Science University - Portland
Pennsylvania
- University of Pennsylvania - Philadelphia
Utah
- University of Utah - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2017-01 |
| Est. Completion | 2028-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03004326
The ClinicalTrials.gov registry entry for NCT03004326 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 27,314-participant average among 11 other Vasculitis trials with a reported enrollment target (100% lower). The listed sponsor is Peter Merkel, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 10 conditions, with Vasculitis appearing as the primary indexed condition, and to 0 interventions.
NCT03004326 reports 10 study locations spanning 9 distinct geographic areas - top geographies include Ontario, California, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT03004326 about?
NCT03004326 is a clinical study titled "Clinical Transcriptomics in Systemic Vasculitis (CUTIS)". Multi-center observational study to evaluate the histopathology and transcriptome of cutaneous lesions in patients with several different types of vasculitis.
What is the current status of trial NCT03004326?
This trial is currently recruiting. The enrollment target is 50 participants. The study started on 2017-01. Estimated completion is 2028-12.
What conditions does trial NCT03004326 study?
This clinical trial studies the following conditions: Vasculitis, IgA Vasculitis, Eosinophilic Granulomatosis With Polyangiitis (EGPA), Granulomatosis With Polyangiitis (GPA), Microscopic Polyangiitis (MPA).
Who is sponsoring clinical trial NCT03004326?
This trial is sponsored by Peter Merkel, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03004326 being conducted?
This trial has 10 study locations across California, Massachusetts, Minnesota, Ohio, Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Vasculitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Longitudinal Study for Relapsing Polychondritis
RECRUITING
-
Infliximab Therapy for Dolichoectactic Vertebrobasilar Aneurysms
RECRUITING · Phase 1
-
A Real-World Registry of Chronic Wounds and Ulcers
RECRUITING
-
Vasculitis Pregnancy Registry
RECRUITING
-
Longitudinal Study for Central Nervous System Vasculitis
RECRUITING
-
Study to Evaluate Avacopan in Combination With a Rituximab or Cyclophosphamide-containing Regimen, in Children From 6 Years to < 18 Years of Age With AAV.
RECRUITING · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.